The interaction of Hsc70 protein with fibrillar α-Synuclein and its therapeutic potential in Parkinson’s disease

References

• Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388:839 - 40; http://dx.doi.org/10.1038/42166; PMID: 9278044
   PubMed Web of Science ®Google Scholar
• Bandopadhyay R, de Belleroche J. Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends Mol Med 2010; 16:27 - 36; http://dx.doi.org/10.1016/j.molmed.2009.11.004; PMID: 20036196
   PubMed Web of Science ®Google Scholar
• Arawaka S, Machiya Y, Kato T. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases. Curr Pharm Biotechnol 2010; 11:158 - 66; http://dx.doi.org/10.2174/138920110790909713; PMID: 20170473
   PubMed Web of Science ®Google Scholar
• Goldfarb SB, Kashlan OB, Watkins JN, Suaud L, Yan W, Kleyman TR, et al. Differential effects of Hsc70 and Hsp70 on the intracellular trafficking and functional expression of epithelial sodium channels. Proc Natl Acad Sci USA 2006; 103:5817 - 22; http://dx.doi.org/10.1073/pnas.0507903103; PMID: 16585520
   PubMed Web of Science ®Google Scholar
• Hageman J, van Waarde MA, Zylicz A, Walerych D, Kampinga HH. The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem J 2011; 435:127 - 42; http://dx.doi.org/10.1042/BJ20101247; PMID: 21231916
   PubMed Web of Science ®Google Scholar
• Pemberton S, Madiona K, Pieri L, Kabani M, Bousset L, Melki R. Hsc70 Protein Interaction with Soluble and Fibrillar {alpha}-Synuclein. J Biol Chem 2011; 286:34690 - 9; http://dx.doi.org/10.1074/jbc.M111.261321; PMID: 21832061
   PubMed Web of Science ®Google Scholar
• Fredenburg RA, Rospigliosi C, Meray RK, Kessler JC, Lashuel HA, Eliezer D, et al. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. Biochemistry 2007; 46:7107 - 18; http://dx.doi.org/10.1021/bi7000246; PMID: 17530780
   PubMed Web of Science ®Google Scholar
• Li J, Uversky VN, Fink AL. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 2001; 40:11604 - 13; http://dx.doi.org/10.1021/bi010616g; PMID: 11560511
   PubMed Web of Science ®Google Scholar
• Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004; 318:121 - 34; http://dx.doi.org/10.1007/s00441-004-0956-9; PMID: 15338272
   PubMed Web of Science ®Google Scholar
• Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11:301 - 7; http://dx.doi.org/10.1038/nrm2873; PMID: 20308987
   PubMed Web of Science ®Google Scholar
• Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous alpha-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death. Neuron 2011; 72:57 - 71; http://dx.doi.org/10.1016/j.neuron.2011.08.033; PMID: 21982369
   PubMed Web of Science ®Google Scholar
• Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, et al. alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 2011; 121:715 - 25; http://dx.doi.org/10.1172/JCI43366; PMID: 21245577
   PubMed Web of Science ®Google Scholar
• Chatellier J, Hill F, Lund PA, Fersht AR. In vivo activities of GroEL minichaperones. Proc Natl Acad Sci USA 1998; 95:9861 - 6; http://dx.doi.org/10.1073/pnas.95.17.9861; PMID: 9707566
   PubMed Web of Science ®Google Scholar
• Golbik R, Zahn R, Harding SE, Fersht AR. Thermodynamic stability and folding of GroEL minichaperones. J Mol Biol 1998; 276:505 - 15; http://dx.doi.org/10.1006/jmbi.1997.1538; PMID: 9512719
   PubMed Web of Science ®Google Scholar
• Zahn R, Buckle AM, Perrett S, Johnson CM, Corrales FJ, Golbik R, et al. Chaperone activity and structure of monomeric polypeptide binding domains of GroEL. Proc Natl Acad Sci USA 1996; 93:15024 - 9; http://dx.doi.org/10.1073/pnas.93.26.15024; PMID: 8986757
   PubMed Web of Science ®Google Scholar